Cargando…
Rescue of chimeric adenoviral vectors to expand the serotype repertoire
The successful use of any adenoviral vectors is predicated upon the use of a serotype that is not neutralized by circulating antibodies. However, efforts to develop a diverse repertoire of serologically distinct adenovirus vectors may be hindered by the necessity to generate cell lines to allow for...
Autores principales: | Roy, Soumitra, Clawson, David S., Lavrukhin, Oleg, Sandhu, Arbans, Miller, Jim, Wilson, James M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868475/ https://www.ncbi.nlm.nih.gov/pubmed/17197043 http://dx.doi.org/10.1016/j.jviromet.2006.11.022 |
Ejemplares similares
-
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
por: Gao, Jian, et al.
Publicado: (2020) -
High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
por: Ricobaraza, Ana, et al.
Publicado: (2020) -
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
por: Peruzzi, Daniela, et al.
Publicado: (2009) -
Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity
por: Keane, John T., et al.
Publicado: (2021) -
Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)